This implication of OPN in breast cancer was further confirmed by our ROC analysis findings which revealed that OPN could significantly discriminate between breast cancer patients and control subjects with a sensitivity of 78%, a specificity of 76%, and an AUC of 0.86. The gene discussed is SPP1; the disease is breast cancer.